The duration of treatment as well as the therapeutic dose of methylprednisolone sodium succinate varies according to the condition. Continuous use of methylprednisolone sodium succinate is usually 3-7 days, depending on the condition, and can be adjusted in time. Methylprednisolone sodium succinate belongs to the glucocorticoid class of drugs, with anti-inflammatory, anticoagulant and anti-shock effects, commonly used in arthritis, such as osteoarthritis or arthritis caused after trauma, rheumatoid arthritis, asthma, contact dermatitis and other allergic diseases. Long-term use of the drug is prone to adverse reactions, such as the induction of atrial fibrillation, arrhythmia, gastrointestinal bleeding, electrolyte disorders and other complications. It is recommended that the drug be used preferably under the conditions of cardiac monitoring in the hospital, and generally the condition can be significantly improved after 3-7 days of continuous use. However, if the symptoms do not improve after 1 week of medication or are progressively aggravated, it is necessary to increase the dose or change the medication according to medical advice. Methylprednisolone sodium succinate is also prone to secondary infections and may even lead to osteoporosis, so close monitoring of the relevant internal environmental indicators should be observed during the drug administration.